95 completed, 17 unknown, 16 terminated, 8 recruiting. 25 Phase 3, 23 Phase 4, 22 Phase 2, 19 Not applicable, 11 Phase 1.
Follow Growth Hormone Deficiency: new trials by email Literature Review of Growth Hormone Deficiency trials Research Report on Growth Hormone Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The AgRP and GH/IGF-1 Axis in Children Growth Hormone Deficiency | Not yet recruiting | Columbia University | 156 | 2027-06-10 | 2026-09-25 | |
| Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels metabolic and auxological outcomes - Growth Hormone Deficiency | Not applicable | Not yet recruiting | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 300 | 2026-07-01 | 2026-05-11 |
| BELux Children OutcoME During A(@)Dulthood With GHD Biological Sample - Growth Hormone Deficiency, Adult Growth Hormone Deficiency | Not applicable | Recruiting | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 200 | 2025-05-21 | 2026-09-21 |
| A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters Somapacitan - Growth Hormone Deficiency, Neoplasms | Enrolling by invitation | Novo Nordisk A/S | 500 | 2024-12-13 | 2026-04-06 | |
| Growing up With the Young Endocrine Support System (YESS!) YESS! game, Snake '97, Transition-toolkit - Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism | Not applicable | Not yet recruiting | dr. Laura C. G. de Graaff-Herder | 160 | 2024-12-01 | 2023-09-07 |
| Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury Not applicable (observational study) - Growth Hormone Deficiency, Traumatic Brain Injury | Recruiting | University of Calgary | 200 | 2024-06-01 | 2026-08-31 | |
| Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH Questionnaire - Growth Hormone Deficiency | Not applicable | Completed | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 500 | 2024-04-15 | 2026-09-21 |
| A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) LUM-201 - Growth Hormone Deficiency | Phase 2 | Enrolling by invitation | Lumos Pharma | 60 | 2023-08-01 | 2024-02-15 |
| Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy Growth Hormone Deficiency, Short Stature | Completed | Istituto Auxologico Italiano | 10 | 2023-06-19 | 2025-09-03 | |
| Effects of GH and Lirglutide on AgRP growth hormone and lirglutide, growth hormone, liraglutide - Healthy, Growth Hormone Deficiency | Phase 4 | Recruiting | Columbia University | 40 | 2023-05-01 | 2026-03-04 |
| Use of miRNAs in Growth Hormone Deficiency (GHD) Growth Hormone Deficiency | Unknown | University of Parma | 400 | 2023-04-13 | 2024-06-13 | |
| A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin No intervention - Growth Hormone Deficiency | Recruiting | Ascendis Pharma Endocrinology Division A/S | 500 | 2023-03-20 | 2026-02-04 | |
| A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA No intervention - Growth Hormone Deficiency | Recruiting | Ascendis Pharma Endocrinology Division A/S | 900 | 2023-03-20 | 2026-04-21 | |
| Growth Hormone Deficiency in Mild Traumatic Brain Injury Growth Hormone, Placebo - Growth Hormone Treatment, Growth Hormone Deficiency | Early Phase 1 | Unknown | University of Calgary | 20 | 2023-02-01 | 2022-12-21 |
| Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4 Questionnaire - Achondroplasia, Small for Gestational Age | Unknown | Universitätsklinikum Hamburg-Eppendorf | 168 | 2022-03-01 | 2022-11-03 | |
| Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) LUM-201 - Growth Hormone Deficiency | Phase 2 | Completed | Lumos Pharma | 15 | 2022-02-18 | 2026-05-15 |
| Isolated Growth Hormone Deficiency and Amennorrhea Hormone panel tests - Growth Hormone Deficiency | Completed | Universitas Padjadjaran | 1 | 2021-12-01 | 2022-07-08 | |
| A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is Macimorelin, Arginine, Clonidine - Growth Hormone Deficiency | Phase 3 | Completed | AEterna Zentaris | 101 | 2021-11-16 | 2024-08-12 |
| Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy Long-Acting Growth Hormone (LAGH) - Growth Hormone Deficiency, Growth Hormone Treatment | Completed | University of Minnesota | 19 | 2021-08-05 | 2024-11-19 | |
| PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212) LUM-201 - Growth Hormone Deficiency | Phase 2 | Active not recruiting | Lumos Pharma | 24 | 2021-07-14 | 2023-10-04 |
Showing 20 of 146. Sign in to see all of them.
Dwarfism, Pituitary (146) · Dwarfism (9) · Turner Syndrome (8) · Hypopituitarism (6) · Acromegaly (5) · Insulin Resistance (5) · Kidney Failure, Chronic (5) · Brain Injuries, Traumatic (4) · Endocrine System Diseases (4) · Pituitary Diseases (4) · Brain Concussion (3) · Failure to Thrive (3) · Heart Failure (3) · Pituitary Neoplasms (3) · Adrenal Hyperplasia, Congenital (2)
Central Nervous System Diseases (146) · Hypothalamic Diseases (146) · Nervous System Diseases (146) · Bone Diseases (145) · Bone Diseases, Developmental (145) · Bone Diseases, Endocrine (145) · Brain Diseases (145) · Musculoskeletal Diseases (145) · Endocrine System Diseases (142) · Pituitary Diseases (142) · Hypopituitarism (140) · Dwarfism (137) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (20) · Genetic Diseases, Inborn (20) · Pathological Conditions, Signs and Symptoms (17)
Human Growth Hormone (43) · Growth Hormone (32) · Blood Specimen Collection (4) · Growth Hormone-Releasing Hormone (4) · Arginine (3) · Injections (3) · Surveys and Questionnaires (3) · albusomatropin (3) · Hematologic Tests (2) · MOD-4023 (2) · Sodium Chloride (2) · X-Rays (2) · lonapegsomatropin (2) · somapacitan (2) · somatrogon (2)
Pfizer (12) · Columbia University (8) · Changchun GeneScience Pharmaceutical Co., Ltd. (7) · Federico II University (5) · Ferring Pharmaceuticals (5) · University of Aarhus (5) · Lumos Pharma (4) · Merck KGaA, Darmstadt, Germany (4) · Teva Branded Pharmaceutical Products R&D, Inc. (4) · Ascendis Pharma Endocrinology Division A/S (3) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (3) · Massachusetts General Hospital (3) · Children's Mercy Hospital Kansas City (2) · EMD Serono (2) · Eli Lilly and Company (2)
United States (52) · Italy (16) · France (15) · Germany (13) · United Kingdom (12) · Israel (9) · Denmark (8) · Slovakia (8) · Spain (8) · China (7) · Czechia (6) · Netherlands (6) · Poland (6) · South Korea (6) · Sweden (6)
Pamela U. Freda, MD (3) · Philippe Lysy, MD, PhD (3) · Antonio Cittadini, MD (2) · Adela Penesova, MD, PhD (1) · Albert Nadal, MD (1) · Alessandro Sartorio, MD (1) · Amira Y Al-Uzri, M.D. (1) · Annamaria AL Colao, Prof. (1) · Anne Klibanski, M.D (1) · Anne Klibanski, MD (1)
PMID 28566441, PMID 10022400, PMID 10199767, PMID 10199774, PMID 10372687, PMID 10405442, PMID 10453734, PMID 10598807, PMID 11134092, PMID 11203878, PMID 11207626, PMID 11273062, PMID 11344175, PMID 11531927, PMID 11839953, PMID 11889170, PMID 12794705, PMID 12924350, PMID 15126541, PMID 15355453, PMID 15540176, PMID 15579750, PMID 15585563, PMID 15671089, PMID 15671099, PMID 15704090, PMID 15760848, PMID 15985481, PMID 16007630, PMID 16394080, PMID 16522693, PMID 16690338, PMID 17579195, PMID 18053120, PMID 18593773, PMID 19181452, PMID 19366847, PMID 19654233, PMID 1973979, PMID 20061426, PMID 20372873, PMID 20484474, PMID 20598930, PMID 20730514, PMID 20961422, PMID 21118739, PMID 21294891, PMID 21648284, PMID 21856788, PMID 22416078
2018 (3), R01DK110771 (2), 2004 (1), 2008 (1), 2014 (1), 2016 (1), M01RR001346 (1), R01AR050618 (1), R01HL085268 (1)